These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0.5 million people. Chen Y; Li L; Zhang Q; Clarke R; Chen J; Guo Y; Bian Z; Pan X; Peto R; Tao R; Shi K; Collins R; Ma L; Sun H; Chen Z; Int J Cardiol; 2014 Mar; 172(1):88-95. PubMed ID: 24461961 [TBL] [Abstract][Full Text] [Related]
6. Estimated total cardiovascular risk in a rural area of Bangladesh: a household level cross-sectional survey done by local community health workers. Zaman MM; Moniruzzaman M; Chowdhury KN; Zareen S; Hossain AE BMJ Open; 2021 Aug; 11(8):e046195. PubMed ID: 34348948 [TBL] [Abstract][Full Text] [Related]
7. Geographic and socioeconomic disparity in cardiovascular risk factors in Indonesia: analysis of the Basic Health Research 2018. Adisasmito W; Amir V; Atin A; Megraini A; Kusuma D BMC Public Health; 2020 Jun; 20(1):1004. PubMed ID: 32586296 [TBL] [Abstract][Full Text] [Related]
8. The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services. Divala OH; Amberbir A; Ismail Z; Beyene T; Garone D; Pfaff C; Singano V; Akello H; Joshua M; Nyirenda MJ; Matengeni A; Berman J; Mallewa J; Chinomba GS; Kayange N; Allain TJ; Chan AK; Sodhi SK; van Oosterhout JJ BMC Public Health; 2016 Dec; 16(1):1243. PubMed ID: 27955664 [TBL] [Abstract][Full Text] [Related]
9. The Burden of Cardiovascular Disease Attributable to Major Modifiable Risk Factors in Indonesia. Hussain MA; Al Mamun A; Peters SA; Woodward M; Huxley RR J Epidemiol; 2016 Oct; 26(10):515-521. PubMed ID: 27021286 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease (CVD) and associated risk factors among older adults in six low-and middle-income countries: results from SAGE Wave 1. Ruan Y; Guo Y; Zheng Y; Huang Z; Sun S; Kowal P; Shi Y; Wu F BMC Public Health; 2018 Jun; 18(1):778. PubMed ID: 29925336 [TBL] [Abstract][Full Text] [Related]
11. Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease. Ofori S; Dodiyi-Manuel S; Akpa MR J Clin Lipidol; 2017; 11(6):1441-1447. PubMed ID: 29050979 [TBL] [Abstract][Full Text] [Related]
12. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea. Liew D; Park HJ; Ko SK Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890 [TBL] [Abstract][Full Text] [Related]
13. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe. Khunti K; Danese MD; Kutikova L; Catterick D; Sorio-Vilela F; Gleeson M; Kondapally Seshasai SR; Brownrigg J; Ray KK JAMA Netw Open; 2018 Dec; 1(8):e185554. PubMed ID: 30646277 [TBL] [Abstract][Full Text] [Related]
14. Estimation of total cardiovascular risk using the 2019 WHO CVD prediction charts and comparison of population-level costs based on alternative drug therapy guidelines: a population-based study of adults in Bangladesh. Islam JY; Zaman MM; Moniruzzaman M; Ara Shakoor S; Hossain AHME BMJ Open; 2020 Jul; 10(7):e035842. PubMed ID: 32690512 [TBL] [Abstract][Full Text] [Related]
15. Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities. Hendriks ME; Wit FW; Roos MT; Brewster LM; Akande TM; de Beer IH; Mfinanga SG; Kahwa AM; Gatongi P; Van Rooy G; Janssens W; Lammers J; Kramer B; Bonfrer I; Gaeb E; van der Gaag J; Rinke de Wit TF; Lange JM; Schultsz C PLoS One; 2012; 7(3):e32638. PubMed ID: 22427857 [TBL] [Abstract][Full Text] [Related]
16. Explaining the increase of incidence and mortality from cardiovascular disease in Indonesia: A global burden of disease study analysis (2000-2019). Harmadha WSP; Muharram FR; Gaspar RS; Azimuth Z; Sulistya HA; Firmansyah F; Multazam CECZ; Harits M; Putra RM PLoS One; 2023; 18(12):e0294128. PubMed ID: 38100501 [TBL] [Abstract][Full Text] [Related]
17. Gaps in antihypertensive and statin treatments and benefits of optimisation: a modelling study in a 1 million ethnically diverse urban population in UK. Wu R; Rison SCG; Raisi-Estabragh Z; Dostal I; Carvalho C; Robson J; Mihaylova B BMJ Open; 2021 Dec; 11(12):e052884. PubMed ID: 35536740 [TBL] [Abstract][Full Text] [Related]
18. Ten-years cardiovascular risk among Bangladeshi population using non-laboratory-based risk chart of the World Health Organization: Findings from a nationally representative survey. Hanif AAM; Hasan M; Khan MSA; Hossain MM; Shamim AA; Hossaine M; Ullah MA; Sarker SK; Rahman SMM; Bulbul MMI; Mitra DK; Mridha MK PLoS One; 2021; 16(5):e0251967. PubMed ID: 34038457 [TBL] [Abstract][Full Text] [Related]
19. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. Chow CK; Teo KK; Rangarajan S; Islam S; Gupta R; Avezum A; Bahonar A; Chifamba J; Dagenais G; Diaz R; Kazmi K; Lanas F; Wei L; Lopez-Jaramillo P; Fanghong L; Ismail NH; Puoane T; Rosengren A; Szuba A; Temizhan A; Wielgosz A; Yusuf R; Yusufali A; McKee M; Liu L; Mony P; Yusuf S; JAMA; 2013 Sep; 310(9):959-68. PubMed ID: 24002282 [TBL] [Abstract][Full Text] [Related]
20. Population-Attributable Risk for Cardiovascular Disease Associated With Hypertension in Black Adults. Clark D; Colantonio LD; Min YI; Hall ME; Zhao H; Mentz RJ; Shimbo D; Ogedegbe G; Howard G; Levitan EB; Jones DW; Correa A; Muntner P JAMA Cardiol; 2019 Dec; 4(12):1194-1202. PubMed ID: 31642869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]